9-134642223-G-A
Variant summary
Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_000093.5(COL5A1):c.36G>A(p.Ala12=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000169 in 1,299,090 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. A12A) has been classified as Likely benign.
Frequency
Consequence
NM_000093.5 synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -17 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
COL5A1 | NM_000093.5 | c.36G>A | p.Ala12= | synonymous_variant | 1/66 | ENST00000371817.8 | |
COL5A1 | NM_001278074.1 | c.36G>A | p.Ala12= | synonymous_variant | 1/66 | ||
COL5A1 | XM_017014266.3 | c.36G>A | p.Ala12= | synonymous_variant | 1/65 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
COL5A1 | ENST00000371817.8 | c.36G>A | p.Ala12= | synonymous_variant | 1/66 | 1 | NM_000093.5 | P4 | |
COL5A1 | ENST00000371820.4 | c.36G>A | p.Ala12= | synonymous_variant | 1/66 | 2 | A2 |
Frequencies
GnomAD3 genomes AF: 0.0000266 AC: 4AN: 150456Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000182 AC: 1AN: 54970Hom.: 0 AF XY: 0.0000305 AC XY: 1AN XY: 32760
GnomAD4 exome AF: 0.0000157 AC: 18AN: 1148634Hom.: 0 Cov.: 31 AF XY: 0.0000161 AC XY: 9AN XY: 558012
GnomAD4 genome AF: 0.0000266 AC: 4AN: 150456Hom.: 0 Cov.: 32 AF XY: 0.0000272 AC XY: 2AN XY: 73406
ClinVar
Submissions by phenotype
Familial thoracic aortic aneurysm and aortic dissection Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 18, 2020 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Ehlers-Danlos syndrome, classic type, 1 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 19, 2022 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at